Trientine hydrochloride is under clinical development by Innolife and currently in Phase II for Coronary Artery Disease (CAD) (Ischemic Heart Disease).
Despite many reports in the literature, recently published guidelines point out the fact that concern remains regarding the optimal strategies for diagnosis and treatment of coronary artery disease in ...
Treatment will depend on your child’s symptoms ... ACA may also increase the risk for early fatty buildup inside the arteries of the heart (coronary artery disease). This increases the risk for a ...